 Michalina Janiszewska
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 7 | 2025 | 353 | 2.020 |
Why?
| | Genetic Heterogeneity | 4 | 2020 | 62 | 1.620 |
Why?
| | Tumor Microenvironment | 7 | 2024 | 732 | 1.550 |
Why?
| | RNA-Binding Proteins | 4 | 2025 | 462 | 1.140 |
Why?
| | Single-Cell Analysis | 4 | 2025 | 356 | 1.040 |
Why?
| | Breast Neoplasms | 6 | 2021 | 2447 | 0.990 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 3 | 2024 | 108 | 0.970 |
Why?
| | Brain Neoplasms | 3 | 2024 | 1318 | 0.890 |
Why?
| | Neoplasms | 7 | 2020 | 2870 | 0.750 |
Why?
| | Mutation | 5 | 2024 | 4085 | 0.730 |
Why?
| | Chromatin | 3 | 2025 | 561 | 0.710 |
Why?
| | Flow Cytometry | 1 | 2025 | 1172 | 0.690 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 881 | 0.640 |
Why?
| | Extracellular Matrix | 1 | 2024 | 553 | 0.610 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 199 | 0.570 |
Why?
| | RNA | 1 | 2025 | 939 | 0.570 |
Why?
| | Transcriptome | 1 | 2025 | 1044 | 0.570 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2024 | 1137 | 0.540 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2143 | 0.530 |
Why?
| | Macrophages | 2 | 2024 | 1510 | 0.510 |
Why?
| | Epigenesis, Genetic | 3 | 2019 | 684 | 0.510 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 688 | 0.490 |
Why?
| | Genes, erbB-2 | 1 | 2015 | 33 | 0.460 |
Why?
| | Cell Movement | 1 | 2020 | 965 | 0.440 |
Why?
| | Neoplastic Stem Cells | 4 | 2016 | 412 | 0.440 |
Why?
| | Epithelial Cells | 1 | 2021 | 1125 | 0.430 |
Why?
| | Clone Cells | 1 | 2015 | 266 | 0.420 |
Why?
| | DNA, Neoplasm | 1 | 2014 | 163 | 0.410 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 928 | 0.400 |
Why?
| | Genome, Human | 2 | 2016 | 422 | 0.390 |
Why?
| | Neutrophils | 1 | 2019 | 1134 | 0.390 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2015 | 379 | 0.390 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 641 | 0.380 |
Why?
| | Telomerase | 2 | 2025 | 247 | 0.370 |
Why?
| | Oxidative Phosphorylation | 1 | 2012 | 210 | 0.340 |
Why?
| | ErbB Receptors | 2 | 2025 | 627 | 0.330 |
Why?
| | Karyopherins | 1 | 2010 | 20 | 0.320 |
Why?
| | Cell Line, Tumor | 10 | 2025 | 3539 | 0.320 |
Why?
| | Hyaluronan Receptors | 1 | 2010 | 102 | 0.310 |
Why?
| | Apoptosis | 1 | 2018 | 2430 | 0.300 |
Why?
| | Cell Nucleus | 2 | 2020 | 618 | 0.280 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2023 | 322 | 0.280 |
Why?
| | Transcription Factors | 4 | 2020 | 1739 | 0.280 |
Why?
| | Protein Binding | 5 | 2025 | 2270 | 0.270 |
Why?
| | Humans | 29 | 2025 | 144261 | 0.260 |
Why?
| | Biomarkers, Tumor | 1 | 2014 | 1313 | 0.260 |
Why?
| | Lung Neoplasms | 1 | 2019 | 2637 | 0.230 |
Why?
| | Scattering, Small Angle | 1 | 2025 | 26 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 1 | 2014 | 2359 | 0.230 |
Why?
| | X-Ray Diffraction | 1 | 2025 | 103 | 0.230 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1495 | 0.220 |
Why?
| | Spatial Analysis | 1 | 2024 | 23 | 0.210 |
Why?
| | Point Mutation | 1 | 2025 | 243 | 0.210 |
Why?
| | Protein Multimerization | 1 | 2025 | 213 | 0.210 |
Why?
| | Lupus Nephritis | 1 | 2024 | 70 | 0.200 |
Why?
| | Podocytes | 1 | 2024 | 80 | 0.200 |
Why?
| | Fibroblasts | 2 | 2021 | 1032 | 0.200 |
Why?
| | Promoter Regions, Genetic | 2 | 2025 | 1255 | 0.190 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2023 | 53 | 0.190 |
Why?
| | Gene Amplification | 1 | 2023 | 120 | 0.190 |
Why?
| | Oncogenes | 1 | 2023 | 119 | 0.180 |
Why?
| | MicroRNAs | 3 | 2016 | 700 | 0.180 |
Why?
| | Light | 1 | 2025 | 410 | 0.180 |
Why?
| | Neuroblastoma | 1 | 2023 | 174 | 0.180 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 2 | 2020 | 56 | 0.180 |
Why?
| | Protein Structure, Tertiary | 2 | 2016 | 862 | 0.170 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 2 | 2011 | 29 | 0.170 |
Why?
| | RNA-Binding Protein EWS | 2 | 2011 | 30 | 0.170 |
Why?
| | Cell Adhesion | 2 | 2020 | 454 | 0.170 |
Why?
| | Neoplasm Transplantation | 1 | 2021 | 251 | 0.160 |
Why?
| | Carcinogenesis | 2 | 2020 | 229 | 0.160 |
Why?
| | Trastuzumab | 1 | 2021 | 118 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 86 | 0.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2020 | 1455 | 0.160 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 183 | 0.160 |
Why?
| | YY1 Transcription Factor | 1 | 2020 | 23 | 0.160 |
Why?
| | Models, Molecular | 1 | 2025 | 1618 | 0.160 |
Why?
| | Genes, Neoplasm | 1 | 2019 | 25 | 0.160 |
Why?
| | Multiple Myeloma | 1 | 2023 | 291 | 0.150 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2020 | 339 | 0.150 |
Why?
| | Oncogene Proteins, Fusion | 2 | 2011 | 210 | 0.140 |
Why?
| | Animals | 9 | 2024 | 38030 | 0.140 |
Why?
| | Cell Communication | 1 | 2020 | 324 | 0.130 |
Why?
| | DNA-Binding Proteins | 2 | 2018 | 1497 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 427 | 0.130 |
Why?
| | Cell Cycle | 1 | 2020 | 596 | 0.130 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 442 | 0.130 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 634 | 0.120 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 215 | 0.120 |
Why?
| | Cell Lineage | 1 | 2018 | 376 | 0.120 |
Why?
| | Embryonic Development | 1 | 2016 | 125 | 0.120 |
Why?
| | Gene Expression Regulation | 3 | 2023 | 2603 | 0.110 |
Why?
| | Azepines | 1 | 2016 | 107 | 0.110 |
Why?
| | Gene Silencing | 1 | 2016 | 205 | 0.110 |
Why?
| | Gene Expression Profiling | 4 | 2016 | 1782 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 985 | 0.110 |
Why?
| | Mice, SCID | 2 | 2012 | 369 | 0.100 |
Why?
| | Triazoles | 1 | 2016 | 184 | 0.100 |
Why?
| | Cell Proliferation | 4 | 2020 | 2494 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4556 | 0.100 |
Why?
| | Tumor Cells, Cultured | 2 | 2012 | 919 | 0.100 |
Why?
| | Biological Evolution | 1 | 2017 | 488 | 0.100 |
Why?
| | Mice, Inbred NOD | 2 | 2012 | 610 | 0.100 |
Why?
| | Sarcoma, Ewing | 2 | 2011 | 102 | 0.100 |
Why?
| | Uncoupling Agents | 1 | 2012 | 4 | 0.090 |
Why?
| | Rotenone | 1 | 2012 | 16 | 0.090 |
Why?
| | Cell Survival | 2 | 2018 | 1098 | 0.090 |
Why?
| | Female | 7 | 2024 | 77976 | 0.090 |
Why?
| | Stem Cells | 1 | 2016 | 625 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 2012 | 247 | 0.090 |
Why?
| | Disease Progression | 1 | 2019 | 2840 | 0.090 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2023 | 31 | 0.080 |
Why?
| | beta Karyopherins | 1 | 2010 | 9 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2016 | 748 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2018 | 4146 | 0.080 |
Why?
| | Middle Aged | 2 | 2024 | 35762 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2010 | 121 | 0.080 |
Why?
| | Precancerous Conditions | 1 | 2011 | 166 | 0.080 |
Why?
| | SOXB1 Transcription Factors | 1 | 2010 | 67 | 0.080 |
Why?
| | Mutagenesis | 1 | 2010 | 190 | 0.070 |
Why?
| | Cellular Reprogramming | 1 | 2010 | 103 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2021 | 8243 | 0.070 |
Why?
| | RNA, Messenger | 2 | 2016 | 2829 | 0.070 |
Why?
| | Mice | 5 | 2024 | 18329 | 0.070 |
Why?
| | Cell Line | 1 | 2012 | 2879 | 0.060 |
Why?
| | Lung | 1 | 2019 | 4108 | 0.060 |
Why?
| | Mitochondria | 1 | 2012 | 983 | 0.060 |
Why?
| | Porphyrins | 1 | 2025 | 16 | 0.060 |
Why?
| | Methane | 1 | 2025 | 51 | 0.050 |
Why?
| | Cetuximab | 1 | 2025 | 111 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 2192 | 0.050 |
Why?
| | Glomerulonephritis | 1 | 2024 | 45 | 0.050 |
Why?
| | Phenotype | 3 | 2020 | 3157 | 0.050 |
Why?
| | Histone Deacetylase 2 | 1 | 2023 | 10 | 0.050 |
Why?
| | Thiazoles | 1 | 2024 | 135 | 0.050 |
Why?
| | Histone Deacetylase 1 | 1 | 2023 | 23 | 0.050 |
Why?
| | Nucleosomes | 1 | 2023 | 165 | 0.040 |
Why?
| | Aged | 1 | 2021 | 25850 | 0.040 |
Why?
| | Cell Fractionation | 1 | 2020 | 52 | 0.040 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2020 | 66 | 0.040 |
Why?
| | Brain | 1 | 2012 | 2930 | 0.040 |
Why?
| | Adult | 2 | 2021 | 40262 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2024 | 876 | 0.040 |
Why?
| | Tumor Hypoxia | 1 | 2017 | 7 | 0.030 |
Why?
| | Ecological and Environmental Phenomena | 1 | 2017 | 6 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 318 | 0.030 |
Why?
| | Male | 1 | 2024 | 72035 | 0.030 |
Why?
| | Mediator Complex Subunit 1 | 1 | 2016 | 6 | 0.030 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2016 | 92 | 0.030 |
Why?
| | Phosphoserine | 1 | 2016 | 27 | 0.030 |
Why?
| | Casein Kinase II | 1 | 2016 | 22 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 744 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1982 | 0.030 |
Why?
| | Antigens, Neoplasm | 1 | 2017 | 271 | 0.030 |
Why?
| | Binding, Competitive | 1 | 2016 | 193 | 0.030 |
Why?
| | Protein Phosphatase 2 | 1 | 2016 | 41 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 73 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2018 | 437 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 621 | 0.030 |
Why?
| | Neural Stem Cells | 1 | 2016 | 166 | 0.030 |
Why?
| | Base Sequence | 1 | 2016 | 2187 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1487 | 0.020 |
Why?
| | Genetic Variation | 1 | 2017 | 982 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 628 | 0.020 |
Why?
| | HMGA2 Protein | 1 | 2011 | 10 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 905 | 0.020 |
Why?
| | Phosphorylation | 1 | 2016 | 1732 | 0.020 |
Why?
| | Nanog Homeobox Protein | 1 | 2010 | 14 | 0.020 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2010 | 19 | 0.020 |
Why?
| | Sarcoma, Synovial | 1 | 2009 | 20 | 0.020 |
Why?
| | Genes, myc | 1 | 2009 | 50 | 0.020 |
Why?
| | Microbiota | 1 | 2017 | 781 | 0.020 |
Why?
| | CpG Islands | 1 | 2009 | 165 | 0.020 |
Why?
| | Translocation, Genetic | 1 | 2009 | 115 | 0.020 |
Why?
| | Proteomics | 1 | 2016 | 1191 | 0.020 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2009 | 81 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 627 | 0.020 |
Why?
| | Alleles | 1 | 2009 | 878 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 5221 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7155 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2010 | 523 | 0.010 |
Why?
| | DNA | 1 | 2009 | 1460 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2010 | 2048 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11643 | 0.010 |
Why?
| | Adolescent | 2 | 2010 | 22281 | 0.010 |
Why?
| | Child | 2 | 2010 | 22537 | 0.010 |
Why?
|
|
Janiszewska's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|